Education
About Us
Working with TipRanks
Follow Us
Neurosense Therapeutics Ltd. (NRSN)
NASDAQ:NRSN
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -22.00K | $ -97.00K | $ -89.00K | $ -3.00K | $ -3.00K |
| Operating Income | $ -9.90M | $ -12.05M | $ -13.55M | $ -5.59M | $ -2.89M |
| EBITDA | $ -9.88M | $ -9.64M | $ -13.38M | $ -2.88M | $ -2.83M |
| Net Income | $ -10.21M | $ -10.11M | $ -10.49M | $ -2.50M | $ -2.83M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 3.38M | $ 2.64M | $ 7.09M | $ 11.06M | $ 699.00K |
| Total Assets | $ 4.58M | $ 3.18M | $ 7.71M | $ 11.43M | $ 779.00K |
| Total Debt | $ 73.00K | $ 142.00K | $ 211.00K | $ 1.83M | $ 0.00 |
| Net Debt | $ -3.31M | $ -2.50M | $ -3.33M | $ -9.23M | $ -699.00K |
| Total Liabilities | $ 1.99M | $ 4.94M | $ 2.09M | $ 2.42M | $ 120.00K |
| Stockholders' Equity | $ 2.58M | $ -1.87M | $ 5.62M | $ 9.01M | $ 659.00K |
| Cash Flow | |||||
| Free Cash Flow | $ -10.14M | $ -8.38M | $ -7.66M | $ -1.56M | $ -704.00K |
| Operating Cash Flow | $ -10.13M | $ -8.35M | $ -7.59M | $ -1.54M | $ -695.00K |
| Investing Cash Flow | $ 1.00K | $ 3.47M | $ -3.54M | $ -17.00K | $ -9.00K |
| Financing Cash Flow | $ 10.91M | $ 3.98M | $ 3.69M | $ 11.90M | $ 508.00K |
Neurosense Therapeutics Ltd. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.